Cyclooxygenase-2 inhibitor treatment of older osteoarthritis patients
| Autor: | Sara Jane Andersen |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
medicine.medical_specialty
Naproxen Peptic Ulcer medicine.medical_treatment Osteoarthritis Pharmacology Internal medicine medicine Humans Cyclooxygenase Inhibitors Drug Interactions Rofecoxib Aged Chemotherapy biology Cyclooxygenase 2 Inhibitors business.industry Age Factors Membrane Proteins General Medicine Valdecoxib medicine.disease Ibuprofen Isoenzymes Endocrinology Cardiovascular Diseases Cyclooxygenase 2 Prostaglandin-Endoperoxide Synthases biology.protein Celecoxib Kidney Diseases Cyclooxygenase Safety business medicine.drug |
| Zdroj: | Comprehensive therapy. 29(4) |
| ISSN: | 0098-8243 |
| Popis: | Nonsteroidal anti-inflammatory drugs are often prescribed to treat osteoarthritis. Two cyclooxygenase isoenzymes prompted the development selective COX-2 inhibitors. The development, efficacy, and toxicity of COX-2 inhibitor treatment of osteoarthritis are summarized. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink